Professor & Head of Section of Cell Biology and Functional Genomics @imperialcollege. Spatiotemporal regulation of signalling of metabolically relevant GPCRs.
Rare GLP1R variants (about 1:500) attenuate weight loss with semaglutide but not tirzepatide, whereas rare LOF GIPR variants have little effect on drug responses
https://t.co/eaIYNd6vDo
They grow up so fast – the birth and development of membrane contact site research
In this Perspective, Tim Levine @timlevine1, Christopher Loewen and William Prinz look back at how the membrane contact site field has developed.
#OpenAccess
https://t.co/6q3XmWx8my
Nice to see the link uncovered between Annexin A11 and ESCRT-III many years after we first described the role of Annexin A11 in cytokinetic abcission: https://t.co/vc6GM7emAB
Amazing 2 days discussing the latest research at the @Soc_Endo Endocrine Metabolic GPCRs 2026 Meeting. Fantastic speakers from different angles: cell biology, physiology, drug discovery, etc. Icing on the cake was our very own PhD student Linda Wong winning the Best Poster Award!
Independent of weight loss, semaglutide (Ozempic) improves knee arthritis by cartilage restoration, in both the mouse model and a small randomized clinical trial
@Cell_Metabolism https://t.co/yy1D1xiMm4
Great opportunity to join us at Imperial - 20 Assistant Professor positions at the Faculty of Medicine have just been advertised. See below:
https://t.co/ykUlewrDri
@DUK_research Thanks to all the coauthors, particularly Denise Wootten and Giuseppe Deganutti for the cryo-EM and MD simulations, and the first author, former PhD student Liliane El Eid
I am delighted to report that our latest paper has now been published in Science Advances:
https://t.co/4zxfrizMSo
In this study, we generated and characterised a humanised GLP‑1R mouse model carrying the gain‑of‑function A316T variant using CRISPR/Cas9 knock‑in technology.
📢We are excited to announce the initial speaker line-up for our #MembraneContactSites conference
⭐️Join us in Mexico in November 2026 to hear directly from the leading researchers in the field
➡️See who’s speaking and reserve your spot here! https://t.co/ccBEvYNiZK
Signaling Architecture of the Glucagon-Like Peptide-1 Receptor
In this contribution to JCI’s Review Series on Clinical Innovation and Scientific Progress in #GLP-1 Medicine, Gregory O Austin & Alejandra Tomas @TomasLab_ICL@imperialcollege explore the spatiotemporal regulation of #GLP-1R signaling: https://t.co/O40Lok2vpF